Create Free Account

By creating account you will get access to hot stocks & personalised emails

Mach7 Technologies Ltd

Healthcare AU M7T

0.325AUD
-0.005(1.52%)

Last update at 2024-12-19T05:11:00Z

Day Range

0.330.34
LowHigh

52 Week Range

0.330.81
LowHigh

Fundamentals

  • Previous Close 0.33
  • Market Cap78.40M
  • Volume1388223
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.56741M
  • Revenue TTM29.13M
  • Revenue Per Share TTM0.12
  • Gross Profit TTM 8.28M
  • Diluted EPS TTM-0.03

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -6.65568M -6.33445M -11.63484M -0.59469M -7.82271M
Minority interest - - - - -
Net income -1.04811M -4.16785M -9.35720M 0.17M -7.05873M
Selling general administrative 27.40M 23.81M 19.13M 11.44M 9.91M
Selling and marketing expenses 0.76M 0.69M 0.14M 0.36M 0.53M
Gross profit 29.06M 26.12M 18.44M 6.25M -0.85924M
Reconciled depreciation 8.68M 9.08M 9.76M 3.87M 3.71M
Ebit -17.16713M -6.27920M -11.32224M -0.52895M -7.44454M
Ebitda -8.48630M 2.80M -1.55991M 3.34M -3.73731M
Depreciation and amortization 8.68M 9.08M 9.76M 3.87M 3.71M
Non operating income net other - - - - -
Operating income -7.37551M -7.03516M -10.73674M -0.81919M -7.39555M
Other operating expenses 6.90M 7.03M 2.16M 5.57M 3.26M
Interest expense 0.05M 0.06M 0.05M 0.04M 0.05M
Tax provision -5.60757M -2.16660M -2.27765M -0.76398M -0.76398M
Interest income 0.71M 0.70M 1.12M 0.25M 0.09M
Net interest income 0.33M -0.02828M -0.00657M -0.04369M -0.01758M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -5.60757M -2.16660M -2.27765M -0.76398M -0.76398M
Total revenue 30.05M 27.08M 19.03M 18.86M 9.35M
Total operating expenses 37.43M 34.12M 29.50M 19.77M 16.85M
Cost of revenue 0.99M 0.96M 0.59M 12.61M 10.21M
Total other income expense net 10.18M 9.20M -1.15753M 0.19M -0.30121M
Discontinued operations - - - - -
Net income from continuing ops -1.04811M -4.16785M -9.35720M 0.17M -7.05873M
Net income applicable to common shares -1.04811M -4.16785M -9.35720M 0.17M -7.05873M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 73.03M 82.31M 78.92M 76.97M 61.62M
Intangible assets - 31.11M 39.01M 45.76M 6.94M
Earning assets - - - - -
Other current assets 0.92M 4.16M 4.04M 3.97M 2.91M
Total liab 21.17M 22.82M 20.55M 19.05M 8.15M
Total stockholder equity 51.86M 59.48M 58.38M 57.91M 53.47M
Deferred long term liab - - - - -
Other current liab 2.46M 2.66M 2.44M 1.39M 2.14M
Common stock 116.24M 115.70M 115.30M 113.75M 101.79M
Capital stock - 115.70M 115.30M 113.75M 101.79M
Retained earnings -71.00547M -63.52575M -63.49543M -61.32982M -51.97263M
Other liab - 7.00M 9.02M 10.76M 1.44M
Good will 4.19M 4.35M 4.30M 4.10M 4.10M
Other assets - 4.95M 1.34M 1.25M 0.76M
Cash 26.18M 23.39M 25.75M 18.36M 48.87M
Cash and equivalents - 16.08M 18.32M 10.41M 19.32M
Total current liabilities 15.09M 14.83M 10.39M 7.49M 6.53M
Current deferred revenue 11.63M 11.22M 7.03M 5.58M 2.78M
Net debt -24.90713M -22.19392M -24.42125M -17.28527M -48.55373M
Short term debt 0.18M 0.21M 0.19M 0.27M 0.13M
Short long term debt - - - - 0.13M
Short long term debt total 1.27M 1.20M 1.33M 1.08M 0.32M
Other stockholder equity - -52.17134M -51.80001M -52.41642M -49.81937M
Property plant equipment - 2.00M 2.07M 1.45M 0.49M
Total current assets 33.27M 34.89M 32.20M 24.40M 53.42M
Long term investments - - - - -
Net tangible assets - 24.02M 15.06M 8.05M 46.52M
Short term investments - - - 0.03M 0.02M
Net receivables 6.17M 6.71M 2.00M 2.07M 1.64M
Long term debt - - - - -
Inventory - 0.63M 0.42M - -
Accounts payable 0.82M 0.74M 0.72M 0.25M 1.47M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 6.62M 7.31M 6.58M 5.50M 3.65M
Additional paid in capital - - - - -
Common stock total equity - - - - 101.79M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 25.02M 5.80M 0.76M 0.70M 0.76M
Deferred long term asset charges - - - - -
Non current assets total 39.76M 47.42M 46.72M 52.57M 8.20M
Capital lease obligations - 1.20M 1.33M 1.08M 0.32M
Long term debt total - 0.99M 1.14M 0.80M 0.19M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments -0.39131M -0.36101M -0.43856M -42.33336M -0.07946M
Change to liabilities - 4.42M 2.97M 1.41M 1.80M
Total cashflows from investing activities - -0.36101M -0.43856M -42.33336M -0.07946M
Net borrowings - -0.25387M -0.41011M -0.29074M -0.77377M
Total cash from financing activities -0.03208M -0.06863M 0.55M 11.21M 41.90M
Change to operating activities - -5.45350M -0.55217M -1.64018M -1.13987M
Net income -7.97032M -1.04811M -4.16785M -9.35720M 0.17M
Change in cash 2.78M -2.35304M 24.85M 19.25M 46.61M
Begin period cash flow 23.39M 25.75M 0.90M -0.88397M 2.27M
End period cash flow 26.18M 23.39M 25.75M 18.36M 48.87M
Total cash from operating activities 3.45M -2.61205M 6.37M 1.50M 4.75M
Issuance of capital stock 0.19M 0.19M 0.96M 12.03M 45.07M
Depreciation 7.25M 1.17M 1.31M 2.47M 2.10M
Other cashflows from investing activities - - 0.00000M -42.23366M -0.00240M
Dividends paid - - - 0.29M -
Change to inventory - 1.03M -2.42223M -0.97686M -0.79080M
Change to account receivables 3.13M -4.62709M 0.08M -0.43271M 0.25M
Sale purchase of stock - - 0.96M -0.52804M -2.39091M
Other cashflows from financing activities -0.39131M -0.25387M -0.41011M -0.29074M -0.13796M
Change to netincome - -4.58872M -1.03190M 1.76M -0.19927M
Capital expenditures 0.15M 0.36M 0.44M 0.10M 0.08M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 4.22M -4.62709M 0.08M -0.43271M 0.25M
Stock based compensation 1.27M 1.08M 1.70M 1.93M 0.70M
Other non cash items -1.32289M -2.73606M 9.23M 8.38M 2.48M
Free cash flow 3.30M -2.97305M 5.94M 1.40M 4.67M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
M7T
Mach7 Technologies Ltd		 -0.005 1.52% 0.33 - - 2.69 1.53 3.17 41.71
PME
Pro Medicus Ltd		 -12.79 4.86% 250.23 318.92 232.56 163.02 137.59 159.06 212.75
ONE
Oneview Healthcare PLC		 -0.005 1.64% 0.30 - - 25.24 29.93 15.53 -3.5247
CGS
CogState Ltd		 -0.105 8.90% 1.07 24.00 26.45 4.77 3.22 2.36 10.34
MDR
Medadvisor Ltd		 -0.015 5.26% 0.27 - 25.97 1.35 3.21 1.33 23.05

Reports Covered

Stock Research & News

View All

Profile

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers enterprise diagnostic viewing, which include eUnity, zero-footprint viewing and vendor independent integration platform; and enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. The company also provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as training and project management, clinical applications, and support and maintenance services. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.

Mach7 Technologies Ltd

120 Kimball Avenue, South Burlington, VT, United States, 05403

Key Executives

Name Title Year Born
Mr. Michael Lampron CEO, MD & Director NA
Mr. Steven Parkes Global Chief Financial Officer NA
Rebecca Thompson Head of Investor Relations NA
Mr. Bob Tranchida VP of Marketing NA
Mr. David Madaffri Exec. VP NA
Ms. Veronique Morgan-Smith Company Sec. NA
Mr. David Madaffri Chief Operating Officer NA
Francoise Dixon Head of Investor Relations NA
Mr. Bob Tranchida Vice President of Marketing NA
Ms. Dyan O'Herne Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.